What is CareDx?
Founded in 1998 and headquartered in South San Francisco, California, CareDx operates as a precision medicine solutions provider. The company is dedicated to the discovery, development, and commercialization of clinically differentiated healthcare solutions tailored for transplant patients and their caregivers. CareDx's comprehensive offerings span testing services, essential products, and digital healthcare solutions that support the entire pre- and post-transplant patient journey. By leveraging genomics-based information, CareDx aims to enhance patient outcomes and provide critical insights within the transplant ecosystem.
How much funding has CareDx raised?
CareDx has raised a total of $98.5M across 5 funding rounds:
Debt
$6M
Debt
$12.5M
Debt
$15M
Stock Offering
$40M
Debt
$25M
Debt (2010): $6M, investors not publicly disclosed
Debt (2011): $12.5M led by GE Capital Healthcare Financial Services
Debt (2012): $15M supported by Oxford Finance Corporation and Silicon Valley Bank
Stock Issuance/Offering (2014): $40M, investors not publicly disclosed
Debt (2017): $25M, investors not publicly disclosed
Key Investors in CareDx
GE Capital Healthcare Financial Services
GE Capital Healthcare Financial Services, a part of GE Capital, is a financial firm offering investment advisory services, with a focus on the healthcare sector.
Oxford Finance Corporation
Oxford Finance Corporation is a specialty finance firm providing flexible financial solutions to companies within the healthcare and life sciences industries globally.
Silicon Valley Bank
Silicon Valley Bank, established in 1983, offers a comprehensive suite of banking and financial services, including commercial and private banking, asset management, and investment services, with a strong presence in the technology and life sciences sectors.
What's next for CareDx?
The substantial enterprise-level funding CareDx has attracted, including its recent major strategic investment, positions the company for accelerated growth and innovation. This capital infusion is expected to fuel further research and development in precision medicine for transplant patients, potentially expanding its service portfolio and market reach. Strategic partnerships and continued technological advancements will likely be key as CareDx navigates the evolving landscape of healthcare solutions, aiming to solidify its leadership in the transplant patient care sector.
See full CareDx company page
